Development of a near anesthetic-free isolated canine hindlimb model. The effects of halothane and atropine sulfate on vascular resistance.
A denervated, isolated canine hindlimb (HL) model was developed to minimize residual anesthetic contamination. To test the preparation, we determined the peripheral arterial vascular effects of atropine sulfate and the effect of the basal anesthetic on arterial resistance. In four dogs that were under halothane and oxygen anesthesia, the HL was prepared to allow either vascular isolation of the limb or continuity with the systemic circulation. During isolation the HL was perfused by roller pump at a preset flow rate through an infant oxygenator. Inspired gas fed to the oxygenator contained either 0%, 1.25%, or 2.5% halothane to determine that anesthetic's effect on HL arterial vascular resistance. No halothane (0%) was used in the oxygenator inflow during the atropine measurements. Vascular resistance was calculated from HL arterial pressure at constant flow. Halothane caused a significant stepwise fall in vascular resistance, with a decrease of 68% at 2.5% inspired concentration (p less than 0.01). Atropine produced a progressive attenuation of resistance that decreased by 18% after the 2.5 mg/kg dose (p less than 0.01). The model proved stable over time and demonstrated an apparent direct, dose-dependent vasodilating effect of both atropine and halothane in the canine HL muscle arterial bed.
Reitan
J A
JA
Department of Anesthesiology, University of California, School of Medicine, Davis 95616.
Kien
N D
ND
Martucci
R W
RW
Thorup
S J
SJ
Dennis
P J
PJ
D000818:Animals; D001285:Atropine / Q000494:pharmacology*; D001775:Blood Circulation / Q000187:drug effects; D002849:Chromatography, Gas; D003714:Denervation; D004195:Disease Models, Animal; D004285:Dogs; D006221:Halothane / Q000097:blood / Q000494:pharmacology*; D006614:Hindlimb / Q000098:blood supply* / Q000187:drug effects; D014655:Vascular Resistance / Q000187:drug effects*
D001285:Atropine; D006221:Halothane